1) antiangiogenic gene therapy
抗血管基因治疗
1.
The authors designed a topical antiangiogenic gene therapy with recombinant human endostatin adenovirus (Ad hEndo) and assessed its effects on the inhibition of angiogenesis in vitro, and tumor growth and metastasis in vivo.
实验中利用重组人内皮抑素腺病毒(recombinanthumanendostatinadenorirus,Ad-hEndo)在肿瘤局部给药以探索其抗血管基因治疗的可行性。
2.
In this study, we designed the antiangiogenic gene therapy with reconbinant soluble Flk-1 adenovirus, to explore its effect on inhibition of tumor growth , and also explore its antitumor effec.
本实验利用鼠可溶性血管内皮生长因子受体2重组腺病毒(重组sFlk-1腺病毒)通过裸鼠尾静脉注射探讨其抗肿瘤血管进而抑制肿瘤生长的抗血管基因治疗可行性。
2) anti-angiogenesis
抗血管治疗
4) anti-angiogenic therapy
抗血管生成治疗
1.
This article presents an overview of tumor anti-angiogenic therapy.
抗血管生成治疗是靶向治疗的重要组成部分,本文回顾分析了近年来肿瘤抗血管生成治疗的最新研究进展情况。
2.
Angiogensis plays an important role in tumor growth and metastasis,and anti-angiogenic therapy is a promising treatment of cancer.
肿瘤新生血管生成在肿瘤的生长和转移过程中起着重要作用 ,抗血管生成治疗可能成为肿瘤治疗的新方法。
5) Vascular endothelia growth factor
抗血管增生治疗
1.
Vascular endothelia growth factor (VEGF) and its receptors (VEGFR) have been implicated in promoting solid tumor growth and metastasis via stimulating tumor-associated angiogenesis.
研究VEGF与白血病的关系,为白血病的抗血管增生治疗提供依据。
6) anti-angiogenesis therapy
抗血管生成治疗
1.
The purpose of the present study is to develop new treatment strategy for pancreatic cancer through combining anti-angiogenesis therapy with gene therapy.
本课题旨在将抗血管生成治疗与基因治疗相结合,探讨胰腺癌治疗新策略。
补充资料：闭塞性脑血管病的溶栓治疗术
闭塞性脑血管病的溶栓治疗术
介入放射学技术。闭塞性脑血管病为因栓塞或血液动力学改变而发生的卒中。脑血管闭塞的介入性溶栓术是为了缩短脑缺血的时间，最大限度地恢复脑功能。溶栓药物为链激酶和尿激酶。先行全脑四条血管造影，明确血栓形成部位。使用1.98mm(6F)与0.99mm(3F)同轴导管，使导管尽可能接近血栓部位，溶栓剂用输液泵经0.99mm(3F)导管输入，也可用球囊导管将栓塞血管的近端闭塞，提高局部浓度。溶栓后，将血管鞘留在血管内，固定在皮肤上，防止穿刺点出现血肿，次日拔出血管鞘压迫止血。出血是最危险并发症，应注意生化监测。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条